The Cigna Group CI
$282.43
+1.41%
at last close
Analyst Consensus
- Consensus Rating
- Buy (13 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $342.88
- Implied Upside
- +21.4%
- Price Target Range
- $302.00 – $400.00
- Analysts (12 mo)
- 17
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-04 | JefferiesDavid Windley |
Downgrades | Buy → Hold | $336 → $307 |
| 2026-08-03 | Raymond JamesJohn Ransom |
Downgrades | Strong buy → Outperform | $350 → $320 |
| 2026-07-31 | Wells FargoStephen Baxter |
Maintains | Equal-weight | $305 → $307 |
| 2026-07-31 | GuggenheimJason Cassorla |
Maintains | Buy | $338 → $361 |
| 2026-07-31 | BarclaysAndrew Mok |
Maintains | Equal-weight | $304 → $310 |
| 2026-07-09 | BernsteinLance Wilkes |
Maintains | Outperform | $371 → $381 |
| 2026-06-08 | MizuhoAnn Hynes |
Maintains | Outperform | $330 → $340 |
| 2026-05-26 | BarclaysAndrew Mok |
Downgrades | Overweight → Equal-weight | $310 → $304 |
| 2026-05-22 | UBSA.J. Rice |
Maintains | Buy | $375 → $400 |
| 2026-05-20 | Morgan StanleyErin Wright |
Maintains | Overweight | $355 → $361 |
| 2026-05-20 | Deutsche BankGeorge Hill |
Downgrades | Buy → Hold | $303 → $302 |
| 2026-05-05 | BernsteinLance Wilkes |
Maintains | Outperform | $358 → $371 |
| 2026-05-04 | GuggenheimJason Cassorla |
Maintains | Buy | $334 → $338 |
| 2026-05-01 | RBC CapitalBen Hendrix |
Maintains | Outperform | $333 → $337 |
| 2026-05-01 | Cantor FitzgeraldSarah James |
Maintains | Overweight | $325 → $340 |
| 2026-05-01 | BarclaysAndrew Mok |
Maintains | Overweight | $303 → $310 |
| 2026-05-01 | Wells FargoStephen Baxter |
Maintains | Equal-weight | $300 → $305 |
| 2026-04-20 | JefferiesDavid Windley |
Maintains | Buy | $333 → $330 |
| 2026-03-12 | BernsteinLance Wilkes |
Upgrades | Market perform → Outperform | $307 → $358 |
| 2026-03-03 | Piper SandlerJessica Tassan |
Reiterates | Overweight | $374 → $370 |
| 2026-02-17 | Truist SecuritiesDavid Macdonald |
Reiterates | Buy | $320 → $350 |
| 2026-02-09 | TD CowenCharles Rhyee |
Maintains | Buy | $333 → $338 |
| 2026-02-06 | RBC CapitalBen Hendrix |
Maintains | Outperform | $344 → $333 |
| 2026-02-06 | BarclaysAndrew Mok |
Maintains | Overweight | $305 → $303 |
| 2026-02-06 | GuggenheimJason Cassorla |
Maintains | Buy | $318 → $334 |
| 2026-02-02 | GuggenheimJason Cassorla |
Reiterates | Buy | $318 |
| 2026-01-05 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $310 → $320 |
| 2026-01-05 | BarclaysAndrew Mok |
Maintains | Overweight | $300 → $305 |
| 2025-11-12 | BernsteinLance Wilkes |
Maintains | Market perform | $346 → $294 |
| 2025-11-05 | Wells FargoStephen Baxter |
Maintains | Equal-weight | $354 → $300 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $282.43
- Market Cap
- $72.75 billion
- 52-Week Range
- $239.51 – $315.47
- Average Volume
- 1.72 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.